PT  - JOURNAL ARTICLE
AU  - Lipka, Alexandra
AU  - Bogner, Wolfgang
AU  - Dal-Bianco, Assunta
AU  - Hangel, Gilbert J.
AU  - Rommer, Paulus S.
AU  - Strasser, Bernhard
AU  - Motyka, Stanislav
AU  - Hingerl, Lukas
AU  - Berger, Thomas
AU  - Leutmezer, Fritz
AU  - Gruber, Stephan
AU  - Trattnig, Siegfried
AU  - Niess, Eva
TI  - Metabolic Insights into Iron Deposition in Relapsing-Remitting Multiple Sclerosis via 7T Magnetic Resonance Spectroscopic Imaging
AID  - 10.1101/2023.03.28.23287856
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.03.28.23287856
4099  - http://medrxiv.org/content/early/2023/09/26/2023.03.28.23287856.short
4100  - http://medrxiv.org/content/early/2023/09/26/2023.03.28.23287856.full
AB  - Objective To investigate the metabolic pattern of different types of iron accumulation in multiple sclerosis (MS) lesions, and compare metabolic alterations within and at the periphery of lesions and newly emerging lesions in vivo according to iron deposition.Methods 7T MR spectroscopic imaging and susceptibility-weighted imaging was performed in 31 patients with relapsing-remitting MS (16 female/15 male; mean age, 36.9 ± 10.3 years). Mean metabolic ratios of four neuro-metabolites were calculated for regions of interest (ROI) of normal appearing white matter (NAWM), “non-iron” (lesion without iron accumulation on SWI), and three distinct types of iron-laden lesions (“rim”: distinct rim-shaped iron accumulation; “area”: iron deposition across the entire lesions; “transition”: transition between “area” and “rim” accumulation shape), and for lesion layers of “non-iron” and “rim” lesions. Furthermore, newly emerging “non-iron” and “iron” lesions were compared longitudinally, as measured before their appearance and one year later.Results Thirty-nine of 75 iron-containing lesions showed no distinct paramagnetic rim. Of these, “area” lesions exhibited a 65% higher mIns/tNAA (p=0.035) than “rim” lesions. Comparing lesion layers of both “non-iron” and “rim” lesions, a steeper metabolic gradient of mIns/tNAA (“non-iron” +15%, “rim” +40%) and tNAA/tCr (“non-iron” −15%, “rim” −35%) was found in “iron” lesions, with the lesion core showing +22% higher mIns/tNAA (p=0.005) and −23% lower tNAA/tCr (p=0.048) in “iron” compared to “non-iron” lesions. In newly emerging lesions, 18 of 39 showed iron accumulation, with the drop in tNAA/tCr after lesion formation remaining significantly lower compared to pre-lesional tissue over time in “iron” lesions (year 0: p=0.013, year 1: p=0.041) as opposed to “non-iron” lesions (year 0: p=0.022, year 1: p=0.231).Conclusion 7T MRSI allows in vivo characterization of different iron accumulation types each presenting with a distinct metabolic profile. Furthermore, the larger extent of neuronal damage in lesions with a distinct iron rim was reconfirmed via reduced tNAA/tCr concentrations, but with metabolic differences in lesion development between (non)-iron-containing lesions. This highlights the ability of MRSI to further investigate different types of iron accumulation and suggests possible implications for disease monitoring.Key pointsIron-containing lesions were suggested as a biomarker for tissue damage, a more aggressive disease course, and worse clinical outcome, but related metabolic alterations are poorly understood.Our MRSI results confirm a higher extent of tissue damage within paramagnetic rim lesions reflected by reduced tNAA/tCr. Forty-six percent of newly emerging lesions showed an iron accumulation, correlating with an altered metabolic behavior compared to non-iron lesions.Only forty-eight percent of iron-containing lesions have a distinct rim-shaped iron accumulation, although most studies focus on these paramagnetic rim lesions. Our results show highly different metabolic profiles (especially with regard to mIns/tNAA and tNAA/tCr) within different iron accumulation types, highlighting the need for distinct classification of iron accumulation in future studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Austrian Science Fund (KLI 718, P 30701, P 34198)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of the Medical University of Vienna gave ethical approval for this work. The approval number is EK 154/2009.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsAbbreviationsEDSSExpanded Disability Status ScalemInsmyo-inositoltNAAtotal N-acetyl aspartateFID-MRSIfree-induction decay magnetic resonance spectroscopic imagingMSmultiple sclerosisNAWMnormal-appearing white matterSWISusceptibility Weighted ImagingtCrtotal creatinetChototal choline